Form 6-K GLAXOSMITHKLINE PLC For: Feb 02
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq fall, dragged by Alphabet and megacap tech; focus on Iran
- Oil falls almost 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Spain's ex-transport minister sentenced to 24 years for corruption
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
GlaxoSmithKline plc (GSK) Reports Q4 EPS of GBP0.22
February 4, 2015 7:10 AM ESTGlaxoSmithKline plc (NYSE: GSK) reported Q4 EPS of GBP0.22, versus GBP0.51 reported last year. Revenue for the quarter came in at GBP6.19 million, versus GBP6.91 million reported last year.
For earnings history and earnings-related data on GlaxoSmithKline plc (GSK) click here.
... More